Metabolomics in detection of Chemotoxicity

Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.

    Related Conference of Metabolomics in detection of Chemotoxicity

    October 10-11, 2022

    International Conference on Biosimilars & Pharmaceuticals

    Amsterdam, Netherlands
    October 24-25, 2022

    5th International Conference on Glycobiology

    Paris, France
    October 27-28, 2022

    2nd Annual Summit on Advanced Bionics

    Rome, Italy
    November 14-15, 2022

    4th International Conference on Biochemistry

    London, UK
    November 14-15, 2022

    4th International Conference on Nucleic Acids

    London, UK
    February 22-23, 2023

    International Bio Summit and Expo

    London, UK
    April 17-18, 2023

    13th World Glycobiology Congress

    Rome, Italy
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy

    Metabolomics in detection of Chemotoxicity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in